Finally playing Defenders of Soma & I have a classic decision to make...add tobra or a FQ for empiric double coverage against an unknown pathogen? 🦠🤔🦠 Each use accrues resistance in the game 😂 #idgeeks#healingblade
Nothing better than getting to chat with longtime friends about nerdy stuff we care about 🤓🦠 Thx, Conan & Majdi!
Check out the new @SIDPharm#Breakpoints pod 🎙️ episode below👇🏻
@ConanMacDougall#IDXposts
🆕 Episode of #Breakpoints:
Join host Dr. Julie Ann Justo and guests Drs. Conan MacDougall & Majdi Al-Hasan for the second installment of a 2️⃣ part series on IV to PO antibiotic transition.
@ConanMacDougall@julie_justo
🎧 https://t.co/XTxayI5cuG
🖥️ https://t.co/KzCLpey1Uh
🚨Sneak Peek: IV to PO Part 2 pod on GNs is coming to you soon! 🎙️
Drs. Majdi Al-Hasan & @ConanMacDougall breakdown the outcomes we should actually be looking for across oral abx regimens for 🦠 GN BSI & more…
@SIDPharm#Breakpoints#IDXposts
A sufficiently fun & nerdy 🤓 podcast conversation on IV to PO abx for GP infxns! Link below & tell us what you think. What PO regimens do you lean on?
Big thanks to @n_mercuro & @andrewhaynes & the @SIDPharm#Breakpoints team 💙🤩💚
🆕 Episode of #Breakpoints:
Join host Dr. Julie Ann Justo and guests Drs. Nicholas Mercuro and Andrew Haynes for the first installment of a ✌🏻part series on IV to PO antibiotic transition
@andrewhaynes@n_mercuro@Julie_Justo
🎧 https://t.co/LIx2XCUZuD
🦠 https://t.co/KzCLpexu4J
Curious about beta-lactam combination therapy for enterococcal bacteremia and endovascular infections? Check out this new narrative review: https://t.co/BsHIgBiyT9
Congratulations to the ACCP ID PRN members who authored this paper!
#IDXposts#Endocarditis#Enterococcus
@CMichaelGibson@MassGenBrigham As presented at @IDWeekmtg 39% of hospitals had a negative operating margin in 2023 and the median operating margin now 2.5%. Three things causing this: higher expenses, more uninsured and flat to lower reimbursement. The “perfect storm” with even more headwinds ahead.
To date, no randomized controlled trials have compared therapeutic doses of Bactrim for PCP!
🆕💥🟢Large Target trial emulation
Comparative effectiveness of trimethoprim-sulfamethoxazole dosing strategies for Pneumocystis jirovecii pneumonia
TMP-SMX dose for PCP treatment was not associated with 30-day mortality after accounting for relevant clinical factors. Lower dosed TMP-SMX may be effective for PCP therapy with less hyperkalemia #idxposts
https://t.co/BVcgHLxGrA
Listen into Episode 143 "Tiny Lungs, Big Protection: RSV Prevention in Infants” paired with an infographic to keep the key points at your fingertips.
PDF version available via our website: https://t.co/KzCLpey1Uh
#infographic#rsvseason
You asked, and we answered! PDF formats will be available on our website for future infographics. Check out the PDF version of our latest infographic for Episode #140 – Beta-lactamase Inhibitors “Scientifically elegant, just complex.” More infographics coming your way soon!
Think you know HSV? Take a closer look 🔍 This infographic reviews the management of resistant and refractory HSV! Developed by SIDP member, Nikki Tran, sponsored by AiCuris US, Inc.
This is an excellent infographic ,a summary of the beta-lactamase inhibitors reviewed in the new @SIDPharm#Breakpoints episode "Beta-lactamase inhibitors: Scientifically elegant, just complex."
Link to podcast: EnJoy! https://t.co/b3bkwBRDkm
#idxposts#bookmark
The countdown begins. Antimicrobials Conference 2027 lands in Baltimore, May 22–26. Come discover what's next in infectious diseases and stewardship. #SIDPharm#MADID#Antimicrobials2027
Nothing is more exciting than the bursting pipeline of beta-lactamase inhibitors. Listen to Drs. Sam Aitken and Christophe Le Terrier, along with host Dr. Erin McCreary, describe enzymology and other properties of beta-lactamase inhibitors in the new episode of Breakpoints. 🔊
This infographic is a fantastic summary of the beta-lactamase inhibitors reviewed in the new #Breakpoints episode "Beta-lactamase inhibitors: Scientifically elegant, just complex." Use this infographic as a reference, and be sure to share!
#infographic#newepisode